Crispr Therapeutics Ag
Clinical trials sponsored by Crispr Therapeutics Ag, explained in plain language.
-
CRISPR breakthrough: new 'Off-the-Shelf' cell therapy fights tough blood cancers
Disease control Recruiting nowThis study is testing a new type of cell therapy called CTX112 for people with B-cell blood cancers that have come back or not responded to other treatments. Doctors use CRISPR gene-editing technology to modify donor immune cells to better target and fight the cancer. The main go…
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
CRISPR One-Shot aims to fix stubborn cholesterol for good
Disease control Recruiting nowThis is the first human trial of an experimental one-time treatment called CTX310, which uses CRISPR gene-editing technology. It aims to permanently lower harmful cholesterol and fat levels in the blood of adults whose levels don't respond well to existing medications. The study …
Phase: PHASE1 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC